BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 26017019)

  • 1. Interventions for prophylaxis of hepatic veno-occlusive disease in people undergoing haematopoietic stem cell transplantation.
    Cheuk DK; Chiang AK; Ha SY; Chan GC
    Cochrane Database Syst Rev; 2015 May; 2015(5):CD009311. PubMed ID: 26017019
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BCSH/BSBMT guideline: diagnosis and management of veno-occlusive disease (sinusoidal obstruction syndrome) following haematopoietic stem cell transplantation.
    Dignan FL; Wynn RF; Hadzic N; Karani J; Quaglia A; Pagliuca A; Veys P; Potter MN; ;
    Br J Haematol; 2013 Nov; 163(4):444-57. PubMed ID: 24102514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mesenchymal stromal cells as treatment or prophylaxis for acute or chronic graft-versus-host disease in haematopoietic stem cell transplant (HSCT) recipients with a haematological condition.
    Fisher SA; Cutler A; Doree C; Brunskill SJ; Stanworth SJ; Navarrete C; Girdlestone J
    Cochrane Database Syst Rev; 2019 Jan; 1(1):CD009768. PubMed ID: 30697701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prophylactic plasma transfusion for patients without inherited bleeding disorders or anticoagulant use undergoing non-cardiac surgery or invasive procedures.
    Huber J; Stanworth SJ; Doree C; Fortin PM; Trivella M; Brunskill SJ; Hopewell S; Wilkinson KL; Estcourt LJ
    Cochrane Database Syst Rev; 2019 Nov; 11(11):CD012745. PubMed ID: 31778223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Defibrotide in the prevention and treatment of veno-occlusive disease in autologous and allogeneic stem cell transplantation in children.
    Qureshi A; Marshall L; Lancaster D
    Pediatr Blood Cancer; 2008 Apr; 50(4):831-2. PubMed ID: 18286502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interventions for preventing thrombosis in solid organ transplant recipients.
    Surianarayanan V; Hoather TJ; Tingle SJ; Thompson ER; Hanley J; Wilson CH
    Cochrane Database Syst Rev; 2021 Mar; 3(3):CD011557. PubMed ID: 33720396
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Restrictive versus liberal red blood cell transfusion strategies for people with haematological malignancies treated with intensive chemotherapy or radiotherapy, or both, with or without haematopoietic stem cell support.
    Estcourt LJ; Malouf R; Trivella M; Fergusson DA; Hopewell S; Murphy MF
    Cochrane Database Syst Rev; 2017 Jan; 1(1):CD011305. PubMed ID: 28128441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Different doses of prophylactic platelet transfusion for preventing bleeding in people with haematological disorders after myelosuppressive chemotherapy or stem cell transplantation.
    Estcourt LJ; Stanworth S; Doree C; Trivella M; Hopewell S; Blanco P; Murphy MF
    Cochrane Database Syst Rev; 2015 Oct; 2015(10):CD010984. PubMed ID: 26505729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatic veno-occlusive disease in pediatric stem cell transplantation: impact of pre-emptive antithrombin III replacement and combined antithrombin III/defibrotide therapy.
    Haussmann U; Fischer J; Eber S; Scherer F; Seger R; Gungor T
    Haematologica; 2006 Jun; 91(6):795-800. PubMed ID: 16769582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interventions for preventing venous thromboembolism in adults undergoing knee arthroscopy.
    Perrotta C; Chahla J; Badariotti G; Ramos J
    Cochrane Database Syst Rev; 2020 May; 5(5):CD005259. PubMed ID: 32374919
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Venous thromboembolism prophylaxis for women at risk during pregnancy and the early postnatal period.
    Middleton P; Shepherd E; Gomersall JC
    Cochrane Database Syst Rev; 2021 Mar; 3(3):CD001689. PubMed ID: 33779986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low molecular weight heparin for prevention of central venous catheter-related thrombosis in children.
    Pelland-Marcotte MC; Amiri N; Avila ML; Brandão LR
    Cochrane Database Syst Rev; 2020 Jun; 6(6):CD005982. PubMed ID: 32557627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Defibrotide for the prevention of hepatic veno-occlusive disease after hematopoietic stem cell transplantation: a systematic review.
    Zhang L; Wang Y; Huang H
    Clin Transplant; 2012; 26(4):511-9. PubMed ID: 22428954
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systemic treatments for the prevention of venous thrombo-embolic events in paediatric cancer patients with tunnelled central venous catheters.
    Schoot RA; Kremer LC; van de Wetering MD; van Ommen CH
    Cochrane Database Syst Rev; 2013 Sep; (9):CD009160. PubMed ID: 24026801
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systematic review of controlled clinical trials on the use of ursodeoxycholic acid for the prevention of hepatic veno-occlusive disease in hematopoietic stem cell transplantation.
    Tay J; Tinmouth A; Fergusson D; Huebsch L; Allan DS
    Biol Blood Marrow Transplant; 2007 Feb; 13(2):206-17. PubMed ID: 17241926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prophylaxis of thromboembolism during therapy with asparaginase in adults with acute lymphoblastic leukaemia.
    Rank CU; Lynggaard LS; Als-Nielsen B; Stock W; Toft N; Nielsen OJ; Frandsen TL; Tuckuviene R; Schmiegelow K
    Cochrane Database Syst Rev; 2020 Oct; 10(10):CD013399. PubMed ID: 33038027
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ursodeoxycholic acid for primary biliary cirrhosis.
    Rudic JS; Poropat G; Krstic MN; Bjelakovic G; Gluud C
    Cochrane Database Syst Rev; 2012 Dec; 12(12):CD000551. PubMed ID: 23235576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological interventions for preventing venous thromboembolism in people undergoing bariatric surgery.
    Amaral FC; Baptista-Silva JC; Nakano LC; Flumignan RL
    Cochrane Database Syst Rev; 2022 Nov; 11(11):CD013683. PubMed ID: 36413425
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prophylactic low-dose heparin or prostaglandin E1 may prevent severe veno-occlusive disease of the liver after allogeneic hematopoietic stem cell transplantation in Korean children.
    Song JS; Seo JJ; Moon HN; Ghim T; Im HJ
    J Korean Med Sci; 2006 Oct; 21(5):897-903. PubMed ID: 17043426
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.